Rivaroxaban

Product NDC
43598-981
11-digit product format
435980981
Labeler code
43598
Product ID
43598-981_eafdf7d8-5014-31c8-daa1-09fc017f5018
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Rivaroxaban
Dosage form
TABLET
Route
ORAL
Labeler
Dr.Reddy's Laboratories, Inc.
Application
ANDA208534
Marketing category
ANDA
Marketing start
2025-05-14
Substance
RIVAROXABAN
Active strength
2.5 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A208534-001RIVAROXABANRIVAROXABAN2.5MGTABLET / ORALAB2025-05-14
A208534-002RIVAROXABANRIVAROXABAN10MGTABLET / ORALAB2025-05-14
A208534-003RIVAROXABANRIVAROXABAN15MGTABLET / ORALAB2025-05-14
A208534-004RIVAROXABANRIVAROXABAN20MGTABLET / ORALAB2025-05-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A208534-001AB
A208534-002AB
A208534-003AB
A208534-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A208534-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-08-18 06:07:402026-07A208534-002RIVAROXABAN10MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-08-18 06:07:402026-07A208534-003RIVAROXABAN15MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-08-18 06:07:402026-07A208534-004RIVAROXABAN20MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A208534-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208534-002RIVAROXABAN10MGTABLET / ORALAB2025-05-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208534-003RIVAROXABAN15MGTABLET / ORALAB2025-05-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208534-004RIVAROXABAN20MGTABLET / ORALAB2025-05-14011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208534-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208534-002RIVAROXABAN10MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208534-003RIVAROXABAN15MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208534-004RIVAROXABAN20MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-08-23 18:47 UTC2025-08A208534-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208534-002RIVAROXABAN10MGTABLET / ORALAB2025-05-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208534-003RIVAROXABAN15MGTABLET / ORALAB2025-05-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208534-004RIVAROXABAN20MGTABLET / ORALAB2025-05-146a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208534-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208534-002RIVAROXABAN10MGTABLET / ORALAB2025-05-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208534-003RIVAROXABAN15MGTABLET / ORALAB2025-05-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208534-004RIVAROXABAN20MGTABLET / ORALAB2025-05-14a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A208534-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A208534-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A208534-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A208534-004AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A208534-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208534-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208534-003AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A208534-004AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208534-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208534-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208534-003AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208534-004AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A208534-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208534-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208534-003AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A208534-004AB16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208534-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208534-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208534-003AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208534-004AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Rivaroxaban
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RIVAROXABAN2.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9NDF7JZ4M3Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2059015Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
122e6f78-067b-9065-adb2-ec7fec9f008eAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6cd5c957-f63d-4ae5-a5e5-4e6830870998Product name320251209
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43598-981-18Rivaroxaban180 in 1 BOTTLETABLET18011
43598-981-60Rivaroxaban60 in 1 BOTTLETABLET6011
43598-981-78Rivaroxaban10 in 1 CARTONTABLET1011
43598-981-79Rivaroxaban10 in 1 BLISTER PACKTABLET1011

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
43598-981-18EA - Each43598-981bf57701e-24b8-4e5a-af0e-4a878f13e7b812025-06-13
43598-981-60EA - Each43598-98101a4d7e7-5f4d-48b9-97bc-421ae341e3e812025-06-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43598-981RIVAROXABAN TABLET [DR.REDDY'S LABORATORIES, INC.]9Current NDC, 4 package rows20250515_122e6f78-067b-9065-adb2-ec7fec9f008e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RivaroxabanRIVAROXABANDr.Reddy's Laboratories, Inc.122e6f78-067b-9065-adb2-ec7fec9f008e2026-04-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 208534
application number: ANDA208534
ndc (product): 43598-981

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2059015rivaroxaban 2.5 MG Oral TabletPSN122e6f78-067b-9065-adb2-ec7fec9f008e11
2059015rivaroxaban 2.5 MG Oral TabletSCD122e6f78-067b-9065-adb2-ec7fec9f008e11

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
43598-981-1843598098118180 TABLET in 1 BOTTLE (43598-981-18) 180 tablet2025-05-14NoNoCurrent
43598-981-604359809816060 TABLET in 1 BOTTLE (43598-981-60) 60 tablet2025-05-14NoNoCurrent
43598-981-784359809817810 BLISTER PACK in 1 CARTON (43598-981-78) / 10 TABLET in 1 BLISTER PACK (43598-981-79) 10 blister pack2025-05-14NoNoCurrent
43598-981-794359809817910 in 1 BLISTER PACKHistorical